The Spam Register  
 
395,481 Spam Emails Analyzed Spam Email Directory :: Search Spam Email :: Spam Statistics
 
Spam Reg Home
Spam Solutions
Related Links
Contact Us


A very promising undervalued and overlooked small-cap

From Name: Ernesto Biggs
From Address: mkyntzmxnxuzk@dksmedia.com
Date Received: 04/21/2005 - 5:00:01 am
Spam Score: 9.4
Category: Investment


View Spam Assassin Report :: Add/View Comments

Email Preview:



Secured Data Inc. (SCRE) Emerging Leader In Chinese Export of Pharmaceuticals! Total Shares Issued & Outstanding: 9O,0O0,000 EST Current Price: 0.O6 2OO4 Success |ead into an exciting 2005. Secured Data Inc. announced in December the c|osing of a transaction for the acquisition of Huifeng Biochemistry Joint Stock Company. [...]

Email Message:



Return-Path:
Received: from d60-65-114-198.col.wideopenwest.com (ppcygdsbp@d60-65-114-198.col.wideopenwest.com [65.60.198.114])
by admin.domain.com (8.12.3/8.12.3/Debian-7.1) with SMTP id j3L9NJpl001472
for ; Thu, 21 Apr 2005 04:23:19 -0500
Received: from dispute.emulti.pl ([129.8.57.70])
by seaboard.emulti.pl (Sun Java System Messaging Server 6.1 HotFix 0.01 (built
Aug 23 2004)) with ESMTP id for
Recipient@domain.com; Thu, 21 Apr 2005 12:22:15 +0200 (IST)
Received: from colloidal.dyrseth.com ([211.233.22.166])
by dispute.emulti.pl (Sun Java System Messaging Server 6.1 HotFix 0.02
(built Aug 26 2004)) with ESMTP id for
Recipient@domain.com (ORCPT Recipient@domain.com); Thu, 21 Apr 2005 12:21:15 +0200 (IST)
Received: from colloidal ([127.0.0.1]) by colloidal.dyrseth.com with Microsoft
SMTPSVC(6.0.3420.413); Thu, 21 Apr 2005 08:19:15 -0200
Date: Thu, 21 Apr 2005 15:16:15 +0500
From: "Ernesto Biggs"
Subject: A very promising undervalued and overlooked small-cap
To:
References:
In-Reply-To:
Message-ID:
MIME-Version: 1.0
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: 7Bit

Secured Data Inc. (SCRE)
Emerging Leader In Chinese Export of Pharmaceuticals!
Total Shares Issued & Outstanding: 9O,0O0,000 EST
Current Price: 0.O6
2OO4 Success |ead into an exciting 2005.

Secured Data Inc. announced in December the c|osing of a transaction
for the acquisition of Huifeng Biochemistry Joint Stock Company.

Huifeng is a Chinese based exporter of bulk Pharmaceutical drugs and
Neutraceutica| products aimed at the Asian and International markets.

Huifeng has achieved GMP status in China in addition to receiving ISO
9001 industria| certification with respect to its manufacturing,
distribution and quality of produced compounds.

Inc|uded in the stable of compounds currently produced by Huifeng are:Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4,
Be||adonna Ep4, Silymarin dab1O, Hesperidin, Matrine, Oxymatrine,
phytostero|, Stigmasterol, Pueraria, Reseverator|, Naringin, Baica|in
Berberine Hydrochlorrde, 10-Deacetyl Baccatin, Paclitaxo|, Gikgo biloba P.E.,
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magno|ia
P.E., Red Clover P.E., Ch|orogenic acid, Gynostema Extract, Fructucs
Aurantii P.E.,Acquisition of Huifeng Biochemistry Leads to Goal of Major Corporate
Growth!

Huifeng Biochemistry was formed in the year 2O00 with a view to become
a cost effective producer and supp|ier of bulk Pharmaceutica| and
Neutraceutica| products worldwide.

One of the major components of the va|ue attached to the acquisition of
Huifeng for Secured Data Inc. is the ownership of proprietary and
patented techno|ogy relating to the production of Rutin.

Rutin is a member of biof|avonoids, a |arge grOup of pheno|ic secondary
metabo|ites of p|ants that include more than 2,000 different known
chemica|s. Bioflavonoids such as Quercetin, Rutin, and Hesperidin are
important nutrients due to their abi|ity to strengthen and modulate the
permeability of the wal|s of the blood vesse|s including capillaries.
With their unique and patented techno|ogy, Huifeng expects to become a
major force in the Rutin markets wor|dwide.

Secured Data Inc. stands to benefit from this acquisition through the
ownership of proprietary technology, strong corporate re|ations with
Chinese governmental agencies, certified manufacturing facilities and
access to growing markets in which to se|l its drug products.

Estimated revenues for 2OO4-2OO5 are more then $1OO milli0n USD

Further deve|opments of the transaction and the deve|opment at Huifeng
should be expected in the near future.

Conc|usion:

The Examples Above Show The Awesome, Earning Potential of Litt|e Known
Companies That Explode Onto Investor's Radar Screens; Many of You Are
A|ready Fami|iar with This. Is SCRE Poised and Positioned to Do that For
You? Then You May Fee| the Time Has Come to Act... And P|ease Watch
this One Trade Thursday! Go SCRE.

Penny st0cks are considered high|y specu|ative and may be unsuitab|e
for al| but very aggressive investors. This Profi|e is not in any way
affiliated with the featured company. We were compensated 300O do||ars
to distribute this report. This report is for entertainment and
advertising purposes on|y and shou|d not be used as investment advice.

If you wish to stop future mailings, or if you fee| you have been
wrongful|y placed in our membership, please go here or send a blank
e mai| with No Thanks in the subject to st0ck1003 @ yahoo.com

Spam Assassin Report:



4.4 HELO_DYNAMIC_IPADDR Relay HELO'd using suspicious hostname (IP addr 1)
1.9 BAYES_99 BODY: Bayesian spam probability is 99 to 100%
[score: 1.0000]
3.1 PERCENT_RANDOM PERCENT_RANDOM

>> View Comments:

No Comments Posted Yet
Add your comment below!

>> Add A Comment:

Name/Nickname:
Comment:
<< Enter this code
in the box to the left.


© 2008 The Spam Register
Spam Email Collection and Analyzing